Stay Informed
of New Reports
Twitter
Where To Report Waste
Fraud, Abuse, Or Retaliation
Where To Report Waste Fraud, Abuse, Or Retaliation

Florida Did Not Invoice Manufacturers for Some Rebates for Physician-Administered Drugs Dispensed to Enrollees of Medicaid Managed-Care Organizations

Submitting OIG: 
Department of Health & Human Services OIG
Date Issued: 
Friday, March 3, 2023
Agency Reviewed / Investigated: 
Department of Health & Human Services
Submitting OIG-Specific Report Number: 
A-04-21-07098
Component, if applicable: 
Centers for Medicare & Medicaid Services
Centers for Medicare and Medicaid Services
External entity, if applicable: 
Florida Agency for Health Care Administration
Location(s): 
US
FL
Type of Report: 
Audit
Questioned Costs: 
$59,898
Funds for Better Use: 
$0
Number of Recommendations: 
1
View Document: 
AttachmentSize
PDF icon 42107098.pdf2.13 MB

Related Open Recommendations

Recommendation Number Recommendation Status Significant Recommendation Additional Details
23-A-04-050.01 Open No
We recommend that the Florida Agency for Health Care Administration invoice for, and collect from manufacturers, an estimated $57,700 ($35,126 Federal share) in rebates for single-source physician-administered drugs and refund the Federal share of rebates collected.
23-A-04-050.03 Open No
We recommend that the Florida Agency for Health Care Administration ensure that all physician-administered drugs eligible for rebates after our audit period are processed for rebates.
Displaying 2 of 2 Recommendations